Status:

RECRUITING

Impact of Virtual Reality on the Quality of Life of Oncology Patients

Lead Sponsor:

Central Hospital Saint Quentin

Conditions:

Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Anxiety, nausea and vomiting are common side effects in paediatric patients receiving chemotherapy. chemotherapy. New evidence supports the efficacy of immersive virtual reality in improving symptoms ...

Detailed Description

For cancer patients, virtual reality proved more effective than other forms of distraction in relieving anxiety, depression and fatigue during chemotherapy. Although pain and anxiety in cancer patient...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Chemotherapy-naive patient
  • Patient with first-line indication for intravenous cyclic chemotherapy
  • Affiliated to a social security system
  • Having received full information on the organization of the research and having given free, informed and written consent signed by the participant and the investigator
  • Patient understands French or English
  • Expected duration of chemotherapy session for the first 3 cycles greater than 30 minutes
  • exclusion criteria :
  • Patient with communication disorders preventing informed consent
  • Patient under legal protection (guardianship, curatorship, safeguard of justice)
  • Patients suffering from epilepsy
  • Severe visual or hearing impairment preventing use of headphones
  • Psychiatric pathologies such as delusional disorders, hallucinations or schizophrenia.
  • Patients with infections or facial wounds
  • Patients with severe claustrophobia
  • Patients with pacemakers
  • Patients with known cognitive or learning problems,
  • Patients with brain tumors or metastases,
  • Patients suffering from motion sickness
  • Expected duration of chemotherapy session for the first 3 cycles of 30 minutes or less.

Exclusion

    Key Trial Info

    Start Date :

    November 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 29 2026

    Estimated Enrollment :

    150 Patients enrolled

    Trial Details

    Trial ID

    NCT06485869

    Start Date

    November 1 2023

    End Date

    August 29 2026

    Last Update

    July 3 2024

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Centre Hospitalier de Chauny

    Chauny, France, 02300

    2

    Centre Hospitalier de Saint Quentin

    Saint-Quentin, France, 02100